Abstract
AbstractThe advancement of dermal fillers has progressed from animal collagen extraction to a spectrum of recombinant DNA, nanotechnology, and biostimulation. Consumers now have a variety of fillers to choose from, including organic fillers composed of hyaluronic acid and calcium hydroxyapatite, as well as synthetic fillers made from poly‐l‐lactic acid and polymethylmethacrylate. This piece serves to add to the open dialogue discussing the prognosis, prospects, and potential pitfalls of dermal fillers. Expansion of product indications and technical alterations are currently changing the dermal fillers' landscape. The potential for new approaches to side effect mitigation or adjunct pigment modification is still exploratory. Furthermore, with social implications increasingly coming into frame, healthcare providers and companies seem geared toward developing effective, safe, and equitable products while maintaining a process of rigorous review and quality control processes. As such, future developments of this medical tool appear promising; fillers seem poised to imbue a role as dynamic as the tissues they were conceived to restore.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
